Gain-of-function mutations, such as RHO gene mutations causing retinitis pigmentosa (RP), can induce the production of cytotoxic proteins and dominant-negative mutations, like RP1 variants in RP, and can lead to the expression of mutated proteins that impair the function of the wild type protein. The gene discussed is RP1; the disease is retinitis pigmentosa 1.